GSK ends Covid-19 collaboration with Vir Biotech

The latest stories trending on MedCity News.

Editor's Pick

Top Story GSK's Covid-19 Valentine to Vir Biotech: 'You Can Go Your Own Way' GSK gave Vir Biotechnology a Valentine's Day break-up message, but it's not a complete goodbye. Though the two companies are ending their Covid-19 collaboration, they'll still work together on other respiratory programs, including a prophylactic influenza antibody drug that is in mid-stage clinical development.

Featured News

Few Managed Care Plans Have Current Contact Info for Medicaid Members as Redeterminations Loom The continuous enrollment requirement, which barred states from disenrolling Medicaid members, will end March 31. About three-quarters of managed care plans anticipate 10% to 25% of their Medicaid enrollees losing coverage once the continuous enrollment provision ends. We're Feeling the Effects of the Nursing Shortage. Technology Can Help. Some providers are still hesitant about certain technology advancements, but this article shows not only how critical tech will be to the healthcare industry at large, but also how it can help to lessen the toll of unpredictable crises, like the pandemic or the insurmountable nursing shortage we're currently facing. Where Are All the Patients? We've always known that patients are out there — but EHR data are the map we need to find them, connect with them, and ultimately engage them in the development of new medicines, therapies, and products that will safely serve everyone in need, regardless of race or ethnicity. Rising Costs Are Keeping Healthcare CFOs Up a Night — Can Data Help? The increasing costs of labor and supplies are the top issues keeping healthcare CFOs up at night, according to a new report. Even though providers' margins are currently quite tight, the report recommended that healthcare organizations adopt data analytics software to remedy these concerns and help with important decisions like how to effectively manage their existing workforce and where to shift care delivery models. Caraway, Ash Wellness Launch Partnership to Combat Rise in STIs on College Campuses Through the partnership, members of Caraway can order an STI Kit, which is delivered to their door and is geared toward Gen Z. The kits have tests for STIs and sexual health, including chlamydia, gonorrhea, syphilis, HIV, hepatitis C, trichomoniasis, candidiasis and bacterial vaginosis. Members then ship the tests to be evaluated at one of Ash's lab partners, and Caraway then reaches out to the patient with results. If treatment is needed, the patients are connected with a provider on Caraway's team.

Resources

Startup 101: Providing Best Practices for Healthcare Entrepreneurs Get the tools necessary to make the right decisions, know what strategies to avoid, and learn how to approach potential healthcare customers.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe